Amgen Inc vs. Editas Medicine, Inc. Common Stock
Amgen Inc (AMGN) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| AMGN | EDIT | |
|---|---|---|
| Market Cap | $208.49 billion | $414.67 million |
| Revenue (TTM) | $38.09 billion | $47.01 million |
| Net Income (TTM) | $8.74 billion | $-73,949,000 |
AMGN leads on 3 of 3 size & scale factors.
Valuation
| AMGN | EDIT | |
|---|---|---|
| P/E Ratio | 23.95 | — |
| Price / Book | 17.84 | 3.94 |
| Price / Sales | 5.47 | 8.82 |
AMGN and EDIT split the valuation factors evenly.
Profitability
| AMGN | EDIT | |
|---|---|---|
| Net Margin | 22.95% | -157.32% |
| Return on Equity | 74.80% | -70.24% |
AMGN leads on 2 of 2 profitability factors.
Dividend
| AMGN | EDIT | |
|---|---|---|
| Dividend Yield | 2.61% | — |
| Payout Ratio | 62.61 | — |
AMGN and EDIT split the dividend factors evenly.
Risk & Sentiment
| AMGN | EDIT | |
|---|---|---|
| Short Interest | 1.66% | 4.06% |
AMGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, EDIT overview, EDIT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.